Top

Archives of Osteoporosis

Published in:

01-12-2023 | Osteoporosis | Original Article

Effect of bedside health education for elderly patients with fragility fracture by specialist physicians on the diagnosis and treatment of osteoporosis during hospitalization and the visiting rate to osteoporosis clinic after discharge in a high-volume orthopedic hospital

Authors: Jiancheng Yang, Qinghua Tang, Maohong Che, Jie Shi, Lei Yang, Yuhong Zeng

Published in: Archives of Osteoporosis | Issue 1/2023

Abstract

Summary

We retrospectively analyzed 12,999 elderly patients with fragility fracture and found that the detection rate of bone mineral density (BMD) and bone turnover markers (BTMs), the treatment rate of osteoporosis, and the visiting rate to the osteoporosis specialist clinic after discharge are significantly enhanced in fragility fracture patients after receiving health education on osteoporosis-related knowledge during hospitalization.

Purpose

To observe the effect of health education on the diagnosis and treatment of osteoporosis during hospitalization and the rate of come back to osteoporosis clinic after discharge in elderly patients with fragility fracture.

Methods

A retrospective analysis was performed on 12,999 elderly patients with fragility fracture admitted to Xi’an Honghui Hospital from March 2021 to December 2022. The patients were divided into the health education group and the non-health education group according to whether they received health education on osteoporosis-related knowledge during hospitalization. The diagnosis and treatment of osteoporosis during hospitalization and the outpatient treatment of osteoporosis after discharge were compared between the two groups.

Results

Among the 7784 patients in the health education group, 4551 (58.47%) received BMD test, 798 (10.25%) received BTMs test, 3990 (51.26%) received anti-osteoporosis medications (AOMs) treatment, and 1232 (15.83%) came back to the osteoporosis specialist clinic after discharge. Among the 5215 patients in the non-health education group, 681 (13.06%) received BMD test, 6 (0.12%) received BTMs test, 2071 (39.71%) received AOMs treatment, and 440 (8.44%) came back to the osteoporosis specialist clinic within one month after discharge.

Conclusion

The education of osteoporosis-related knowledge for patients with fragility fracture contribute to enhance the detection rate of BMD and BTMs and the treatment rate of osteoporosis during hospitalization, and increase the rate of coming back to the osteoporosis clinic after discharge.

Wang L, Yu W, Yin X, Cui L, Tang S, Jiang N, Cui L, Zhao N, Lin Q, Chen L, Lin H, Jin X, Dong Z, Ren Z, Hou Z, Zhang Y, Zhong J, Cai S, Liu Y, Meng R, Deng Y, Ding X, Ma J, Xie Z, Shen L, Wu W, Zhang M, Ying Q, Zeng Y, Dong J, Cummings SR, Li Z, Xia W (2021) Prevalence of osteoporosis and fracture in China: the China Osteoporosis Prevalence Study. JAMA Netw Open 4(8):e2121106. https://doi.org/10.1001/jamanetworkopen.2021.21106CrossRefPubMedPubMedCentral

Odén A, McCloskey EV, Kanis JA, Harvey NC, Johansson H (2015) Burden of high fracture probability worldwide: secular increases 2010–2040. Osteoporos Int 26(9):2243–2248. https://doi.org/10.1007/s00198-015-3154-6CrossRefPubMed

Åkesson K, Marsh D, Mitchell PJ, McLellan AR, Stenmark J, Pierroz DD, Kyer C, Cooper C, Group IOFFW (2013) Capture the fracture: a best practice framework and global campaign to break the fragility fracture cycle. Osteoporosis International 24(8):2135–2152. https://doi.org/10.1007/s00198-013-2348-zCrossRefPubMedPubMedCentral

Pisani P, Renna MD, Conversano F, Casciaro E, Di Paola M, Quarta E, Muratore M, Casciaro S (2016) Major osteoporotic fragility fractures: risk factor updates and societal impact. World J Orthop 7(3):171–181. https://doi.org/10.5312/wjo.v7.i3.171CrossRefPubMedPubMedCentral

Cheung C-L, Ang SB, Chadha M, Chow ES-L, Chung Y-S, Hew FL, Jaisamrarn U, Ng H, Takeuchi Y, Wu C-H, Xia W, Yu J, Fujiwara S (2018) An updated hip fracture projection in Asia: the Asian Federation of Osteoporosis Societies study. Osteoporosis and Sarcopenia 4(1):16–21. https://doi.org/10.1016/j.afos.2018.03.003CrossRefPubMedPubMedCentral

Kanis JA (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. Osteoporos Int 4(6):368–381. https://doi.org/10.1007/BF01622200CrossRefPubMed

Eastell R, Szulc P (2017) Use of bone turnover markers in postmenopausal osteoporosis. Lancet Diabetes endocrinol 5(11):908–923. https://doi.org/10.1016/s2213-8587(17)30184-5CrossRefPubMed

Sorbi R, Aghamirsalim MR (2012) Knowledge of orthopaedic surgeons in managing patients with fragility fracture. Int Orthop 36(6):1275–1279. https://doi.org/10.1007/s00264-012-1482-0CrossRefPubMedPubMedCentral

Kim S-R, Park Y-G, Kang SY, Nam KW, Park Y-G, Ha Y-C (2014) Undertreatment of osteoporosis following hip fractures in jeju cohort study. J Bone Metab 21(4):263–268. https://doi.org/10.11005/jbm.2014.21.4.263CrossRefPubMedPubMedCentral

10.

Kim S-R, Ha Y-C, Park Y-G, Lee S-R, Koo K-H (2011) Orthopedic surgeon’s awareness can improve osteoporosis treatment following hip fracture: a prospective cohort study. J Korean Med Sci 26(11):1501–1507. https://doi.org/10.3346/jkms.2011.26.11.1501CrossRefPubMedPubMedCentral

11.

Song S, Guo Y, Yang Y, Fu D (2022) Advances in pathogenesis and therapeutic strategies for osteoporosis. Pharmacol Ther 237:108168. https://doi.org/10.1016/j.pharmthera.2022.108168CrossRefPubMed

12.

Brown JP, Don-Wauchope A, Douville P, Albert C, Vasikaran SD (2022) Current use of bone turnover markers in the management of osteoporosis. Clin Biochem 109–110:1–10. https://doi.org/10.1016/j.clinbiochem.2022.09.002CrossRefPubMed

13.

Greenspan SL, Wyman A, Hooven FH, Adami S, Gehlbach S, Anderson FA Jr, Boone S, Lacroix AZ, Lindsay R, Coen Netelenbos J (2012) Predictors of treatment with osteoporosis medications after recent fragility fractures in a multinational cohort of postmenopausal women. J Am Geriatr Soc 60(3):455–461. https://doi.org/10.1111/j.1532-5415.2011.03854.xCrossRefPubMedPubMedCentral

14.

Wilk A, Sajjan S, Modi A, Fan C-P, Mavros P (2014) Post-fracture pharmacotherapy for women with osteoporotic fracture: analysis of a managed care population in the USA. Osteoporos Int 25(12):2777–2786. https://doi.org/10.1007/s00198-014-2827-xCrossRefPubMedPubMedCentral

15.

Gillespie CW, Morin PE (2017) Osteoporosis-related health services utilization following first hip fracture among a cohort of privately-insured women in the United States, 2008–2014: an observational study. J Bone Miner Res 32(5):1052–1061. https://doi.org/10.1002/jbmr.3079CrossRefPubMed

16.

Hagino H, Sawaguchi T, Endo N, Ito Y, Nakano T, Watanabe Y (2012) The risk of a second hip fracture in patients after their first hip fracture. Calcif Tissue Int 90(1):14–21. https://doi.org/10.1007/s00223-011-9545-6CrossRefPubMed

17.

Vellucci R, Terenzi R, Kanis J, Kress H, Mediati R, Reginster J-Y, Rizzoli R, Brandi ML (2018) Understanding osteoporotic pain and its pharmacological treatment. Osteoporos Int 29(7):1477–1491. https://doi.org/10.1007/s00198-018-4476-yCrossRefPubMed

18.

Watts NB, Camacho PM, Lewiecki EM, Petak SM (2021) American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis-2020 Update. Endocr Pract 27(4):379–380. https://doi.org/10.1016/j.eprac.2021.02.001CrossRefPubMed

19.

Gregson CL, Armstrong DJ, Bowden J, Cooper C, Edwards J, Gittoes NJL, Harvey N, Kanis J, Leyland S, Low R, McCloskey E, Moss K, Parker J, Paskins Z, Poole K, Reid DM, Stone M, Thomson J, Vine N, Compston J (2022) UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos 17(1):58. https://doi.org/10.1007/s11657-022-01061-5CrossRefPubMedPubMedCentral

20.

Qaseem A, Hicks LA, Etxeandia-Ikobaltzeta I, Shamliyan T, Cooney TG (2023) Pharmacologic treatment of primary osteoporosis or low bone mass to prevent fractures in adults: a living clinical guideline from the American College of Physicians. Ann Intern Med. https://doi.org/10.7326/m22-1034CrossRefPubMedPubMedCentral

Title: Effect of bedside health education for elderly patients with fragility fracture by specialist physicians on the diagnosis and treatment of osteoporosis during hospitalization and the visiting rate to osteoporosis clinic after discharge in a high-volume orthopedic hospital
Authors: Jiancheng Yang
Qinghua Tang
Maohong Che
Jie Shi
Lei Yang
Yuhong Zeng
Publication date: 01-12-2023
Publisher: Springer London
Keywords: Osteoporosis
Osteoporosis
Bisphosphonate
Published in: Archives of Osteoporosis / Issue 1/2023
Print ISSN: 1862-3522
Electronic ISSN: 1862-3514
DOI: https://doi.org/10.1007/s11657-023-01345-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Effect of bedside health education for elderly patients with fragility fracture by specialist physicians on the diagnosis and treatment of osteoporosis during hospitalization and the visiting rate to osteoporosis clinic after discharge in a high-volume orthopedic hospital

Abstract

Summary

Purpose

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Summary

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2023

Increasing baseline aortic valve peak flow velocity is associated with progression of aortic valve stenosis in osteoporosis patients—a possible link to low vitamin D status

First Ecuadorian consensus statement on the management of osteoporosis

Incident vertebral fracture and longitudinal BMD change in Chinese postmenopausal women with early CKD: Peking Vertebral Fracture Study

Upturn in osteoporotic hip fracture incidence following the COVID-19 pandemic

Optimal fracture prediction thresholds for therapy onset, established from FRAX and Garvan algorithms: a longitudinal observation of the population representative female cohort from the RAC-OST-POL Study

Mortality following fragility hip fracture in China: a record linkage study